← Back to all trials
Not Yet Recruiting
NCT07716202
Homeless Overdose Prevention- Expansion
Conditions: Homelessness, Opioid Education and Naloxone Distribution (OEND), Substance Use Disorder
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 1200
Sponsor: VA Office of Research and Development
Location: VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California
Summary
Homeless Overdose Prevention - Expansion (HOPE), tests implementation of overdose education and naloxone distribution (OEND), a program that targets homeless experienced Veterans at risk for overdose, including Veterans in community-based supportive housing. HOPE sites will receive a playbook that offers step-by-step instructions, tools, templates, and checklists tailorable to site needs; sites will also receive performance feedback about their performance relative to a standard or benchmark.
Eligibility Criteria
Inclusion Criteria:
* Veterans enrolled in HUD-VASH at risk for opioid overdose (based on existing HOPE algorithms aligned with Pharmacy Benefit Manager data definitions), drawing from VA administrative data.
Exclusion Criteria:
* Not flagged by existing HOPE algorithms
* Not currently enrolled in HUD-VASH
* Is not a patient at a participating site of the implementation trial
Source: ClinicalTrials.gov (NCT07716202). StuddyBuddy aggregates publicly available trial information.
